• Latest

Positive results from Novartis five-year VERIFY study in type 2 diabetes demonstrate long-term clinical benefits of early combination treatment with vildagliptin and metformin

Early combination treatment strategy with vildagliptin and metformin was superior to standard of care in newly diagnosed type 2 diabetes…

Diabetic Drugs: Research and Development Initiatives for the Introduction of Improved Drugs will Accentuate the Growth of Global Market

New York, August 27, 2018: Diabetes is a chronic medical condition wherein insulin is produced in insufficient amount, or if…